Vertiv Expands Power Protection Portfolio with Launch of Vertiv PowerUPS 100 Standby Series in North America Samsung Electronics Chip Workers Reach Tentative Deal for Average 432000 Bonuses Amid Strike Resolution UK Seals Historic Trade Deal with Gulf States Poised to Boost Economy by Billions Berenberg Economist Warns ECB Rate Hikes a Big Mistake Amid Stagflation Concerns OpenAI Eyes Landmark IPO Potential RecordBreaking Stock Market Debut on the Horizon AMD Announces Over 10 Billion Investment in Taiwans AI and Chip Ecosystem to Boost NextGen Processors Edgewell Personal Care EPC Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher DORM Q1 2026 Earnings EPS Misses Estimates Despite Slight Positive Market Response Chime Financial Inc CHYM Q1 2026 Earnings Robust EPS Beat Defies Market Skepticism Union Bankshares Inc UNB Q2 2025 Earnings Shares Gain on Reported EPS of 053 CRWD Q1 2026 Earnings EPS Slightly Misses Estimates Stock Drops 39 SOFI Q1 2026 Earnings EPS Slightly Below Estimates Stock Dips Marginally National Vision Holdings EYE Edges Higher Approaching Key Resistance Level Taboola Shares Slide as Market Weighs Growth Prospects Equus Total Return Inc EQS Moves Higher as Price Approaches Key Resistance ZOOZ Strategy Ltd ZOOZ Edges Higher Toward Key Resistance at 033 indie Semiconductor INDI Surges Over 15 as Bullish Momentum Builds SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags SGRP Q4 2024 Earnings EPS Misses Estimates Amidst Undisclosed Revenue Hudson Technologies HDSN Slides 21 as Key Support Level Approaches Stellar SVCCW Stock Analysis No Movement at 020 What It Means 20260527 RZC Holds Steady Near Par as Investors Assess FixedRate Reset Features AMTD Digital Inc HKD Posts 444 Gain Testing Resistance at 185 Ideal Power Inc IPWR Surges Over 21 as Strong Volume Drives Breakout Above Support New York Times NYT Holds Steady Near 75 as Digital Subscription Growth Fuels Modest Gains Rithm Acquisition Corp RAC Holds Steady Near Support A Period of Consolidation for the SPAC TransCode Therapeutics RNAZ Drops 1066 Support at 53 Faces Critical Test After Sharp Decline